0.09
-0.005(-5.56%)
Currency In CAD
Sector
Healthcare
Industry
Medical - Devices
Employees
N/A
First IPO Date
September 26, 2007
| Name | Title | Pay | Year Born |
| Mr. Hugh MacNaught | Chief Executive Officer, President & Director | 12,000 | N/A |
| Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. | Executive Chairman & Corporate Secretary | 286,000 | 1953 |
| Mr. Hirotaka Katagiri | Chief Technology Officer & Business Development Division Director | 0 | N/A |
| Mr. Jim Graba | Application Specialist & Chief Trainer | 0 | N/A |
| Mr. Matt Dobson | Marketing Director | 0 | N/A |
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.